Evidence map›Paper›PMID 40044820›Full record

ArticleScientific reports2025

Attention dual transformer with adaptive temporal convolutional for diabetic retinopathy detection.

Mishmala Sushith, Ajanthaa Lakkshmanan, M Saravanan, S Castro

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mishmala SushithDepartment of Information Technology, Adithya Institute of Technology, Kurumbapalayam, Coimbatore, Tamil Nadu, 641107, India. mishmalasushith1926@gmail.com.
Ajanthaa LakkshmananDepartment of Computing Technologies, School of Computing, SRM Institute of Science and Technology, Kattankaluthur, Chengalpattu, Tamil Nadu, 603203, India.
M SaravananDepartment of Electronics and Communication Engineering, Faculty of Engineering and Technology, Annamalai University, Chidambaram, Tamil Nadu, 608002, India.
S CastroDepartment of Information Technology, Karpagam College of Engineering, Coimbatore, Tamil Nadu, 641032, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An Attention Dual Transformer with Adaptive Temporal Convolutional (ADT-ATC) model is proposed in this research work for enhanced detection of Diabetic Retinopathy (DR) from retinal fundus images. Unlike traditional methods which evolved so far in DR analysis, the proposed model specifically processes the multi-scale spatial features through dual spatial transformer network and captures the temporal dependencies through adaptive temporal convolutional unit. The fine patterns like microaneurysms, and larger anatomical regions, including hemorrhages are focused on dual spatial transformer block which provides comprehensive and detailed analysis of spatial features. Additionally, a hierarchical cross attention module is included to fuse the spatial and temporal features which is essential to identify the DR. Experimentation of the proposed model using DRIVE and Diabetic Retinopathy datasets demonstrates the better performance of proposed ADTATC model with an accuracy of 98.2% on DRIVE and 97.7% on Diabetic Retinopathy datasets compared to conventional deep learning models.

Indexed as

Diabetic RetinopathyImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedAlgorithmsDeep LearningFundus OculiHumansRetinaDeep learningDiabetic retinopathy detectionSpatial and temporal featuresTemporal convolutional NetworkTransformer network

Identifiers

PMID40044820
PMCPMC11882789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.